| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |